Status:
COMPLETED
A Mediterranean Intervention on Prediabetic Children
Lead Sponsor:
Pilar Aparicio Martinez
Collaborating Sponsors:
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
Conditions:
Prediabetic State
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Prediabetes is a pathological condition where the blood glucose concentration is higher than normal concentrations but lower than those considered in type 2 diabetes mellitus (DM2) diagnosis. Until a ...
Eligibility Criteria
Inclusion
- Presence of HbA1c levels between 5.7 and 6.4% in the blood tests
- Signed informed consent by the minor
- Signed informed consent by the minor's parents or guardians.
Exclusion
- Presence of HbA1c levels below 5.7%
- Presence of HbA1c levels above 6.4%
- Presence of pathological metabolic diseases, such as diabetes or metabolic syndrome
- Lack of the signed informed consent by the minor and legal guardian
Key Trial Info
Start Date :
September 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2022
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT05424107
Start Date
September 4 2018
End Date
June 10 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayuntamiento de Pedra Abad
Córdoba, Spain